Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | GNX102 |
Trade Name | |
Synonyms | GNX-102|GNX 102 |
Drug Descriptions |
GNX102 is a monoclonal antibody targeting the Lewis B and Lewis Y glycans, which may lead to antibody-dependent cellular cytotoxicity (ADCC) against tumor cells expressing these glycans (NCI Drug Dictionary). |
DrugClasses | |
CAS Registry Number | NA |
NCIT ID | C175411 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
GNX102 | GNX102 | 0 | 1 |